ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus
Authors:
- Makiko SaitohMSMakiko Saitoh
- Daisuke NishizawaDNDaisuke Nishizawa
- Kazutaka IkedaKIKazutaka Ikeda
- Shinichi HiroseSHShinichi Hirose
- Jun-Ichi TakanashiJTJun-Ichi Takanashi
- Junko TakitaJTJunko Takita
- Kenjiro KikuchiKKKenjiro Kikuchi
- Masaya KubotaMKMasaya Kubota
- Gaku YamanakaGYGaku Yamanaka
- Takashi ShiiharaTSTakashi Shiihara
- Akira KumakuraAKAkira Kumakura
- 23 April 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 80 (17) , 1571-1576
Abstract
Objective: Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a childhood encephalopathy following severe febrile seizures, leaving neurologic sequelae in many patients. However, its pathogenesis remains unclear. In this study, we clarified that genetic variation in the adenosine A2A receptor (ADORA2A), whose activation is involved in excitotoxicity, may be a predisposing factor of AESD. Methods: We analyzed 4 ADORA2A single nucleotide polymorphisms in 85 patients with AESD. The mRNA expression in brain samples, mRNA and protein expression in lymphoblasts, as well as the production of cyclic adenosine monophosphate (cAMP) by lymphoblasts in response to adenosine were compared among ADORA2A diplotypes. Results: Four single nucleotide polymorphisms were completely linked, which resulted in 2 haplotypes, A and B. Haplotype A (C at rs2298383, T at rs5751876, deletion at rs35320474, and C at rs4822492) frequency in patients was significantly higher than in controls (p = 0.005). Homozygous haplotype A (AA diplotype) had a higher risk of developing AESD (odds ratio 2.32, 95% confidence interval 1.32–4.08; p = 0.003) via a recessive model. mRNA expression was significantly higher in AA than AB and BB diplotypes, both in the brain (p = 0.003 and 0.002, respectively) and lymphoblasts (p = 0.035 and 0.003, respectively). In lymphoblasts, ADORA2A protein expression (p = 0.024), as well as cellular cAMP production (p = 0.0006), was significantly higher in AA than BB diplotype. Conclusions: AA diplotype of ADORA2A is associated with AESD and may alter the intracellular adenosine/cAMP cascade, thereby promoting seizures and excitotoxic brain damage in patients.Keywords
This publication has 28 references indexed in Scilit:
- Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseasesBrain and Development, 2011
- Acute encephalopathy with inflammation-mediated status epilepticusThe Lancet Neurology, 2011
- Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptorsNature Neuroscience, 2010
- Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine ConsumptionNeuropsychopharmacology, 2010
- Excitotoxicity in Acute Encephalopathy with Biphasic Seizures and Late Reduced DiffusionAmerican Journal of Neuroradiology, 2008
- Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced AnxietyNeuropsychopharmacology, 2008
- Acute encephalopathy associated with influenza and other viral infectionsActa Neurologica Scandinavica, 2007
- PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposesNucleic Acids Research, 2006
- Adenosine Receptor Subtypes: Characterization and Therapeutic RegulationAnnual Review of Pharmacology and Toxicology, 1995
- The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortexNeuroscience Letters, 1992